150 related articles for article (PubMed ID: 26050796)
1. Development of a pharmacogenetic-based warfarin dosing algorithm and its performance in Brazilian patients: highlighting the importance of population-specific calibration.
Santos PC; Marcatto LR; Duarte NE; Gadi Soares RA; Cassaro Strunz CM; Scanavacca M; Krieger JE; Pereira AC
Pharmacogenomics; 2015 Jul; 16(8):865-76. PubMed ID: 26050796
[TBL] [Abstract][Full Text] [Related]
2. Development and Comparison of Warfarin Dosing Algorithms in Stroke Patients.
Cho SM; Lee KY; Choi JR; Lee KA
Yonsei Med J; 2016 May; 57(3):635-40. PubMed ID: 26996562
[TBL] [Abstract][Full Text] [Related]
3. Development and comparison of a warfarin-dosing algorithm for Korean patients with atrial fibrillation.
Cho HJ; On YK; Bang OY; Kim JW; Huh W; Ko JW; Kim JS; Lee SY
Clin Ther; 2011 Oct; 33(10):1371-80. PubMed ID: 21981797
[TBL] [Abstract][Full Text] [Related]
4. Implementing Algorithm-Guided Warfarin Dosing in an Ethnically Diverse Patient Population Using Electronic Health Records and Preemptive CYP2C9 and VKORC1 Genetic Testing.
Obeng AO; Kaszemacher T; Abul-Husn NS; Gottesman O; Vega A; Waite E; Myers K; Cho J; Bottinger EP; Ellis SB; Scott SA
Clin Pharmacol Ther; 2016 Nov; 100(5):427-430. PubMed ID: 27393744
[TBL] [Abstract][Full Text] [Related]
5. Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations.
Wu AH; Wang P; Smith A; Haller C; Drake K; Linder M; Valdes R
Pharmacogenomics; 2008 Feb; 9(2):169-78. PubMed ID: 18370846
[TBL] [Abstract][Full Text] [Related]
6. Failure of pharmacogenetic-based dosing algorithms to identify older patients requiring low daily doses of warfarin.
Schwartz JB; Kane L; Moore K; Wu AH
J Am Med Dir Assoc; 2011 Nov; 12(9):633-8. PubMed ID: 21450231
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of VKORC1 (G-1639A and C1173T) and CYP2C9*3 among patients on warfarin.
Teh LK; Langmia IM; Fazleen Haslinda MH; Ngow HA; Roziah MJ; Harun R; Zakaria ZA; Salleh MZ
J Clin Pharm Ther; 2012 Apr; 37(2):232-6. PubMed ID: 21507031
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation endpoints with clinical implementation of warfarin pharmacogenetic dosing in a real-world setting: A proposal for a new pharmacogenetic dosing approach.
Arwood MJ; Deng J; Drozda K; Pugach O; Nutescu EA; Schmidt S; Duarte JD; Cavallari LH
Clin Pharmacol Ther; 2017 May; 101(5):675-683. PubMed ID: 28032893
[TBL] [Abstract][Full Text] [Related]
9. Impact of CYP2C9 and VKORC1 genetic polymorphisms upon warfarin dose requirements in Egyptian patients with acute coronary syndrome.
Ghozlan MF; Foad DA; Darwish YW; Saad AA
Blood Coagul Fibrinolysis; 2015 Jul; 26(5):499-504. PubMed ID: 25699611
[TBL] [Abstract][Full Text] [Related]
10. Verification of pharmacogenomics-based algorithms to predict warfarin maintenance dose using registered data of Japanese patients.
Sasano M; Ohno M; Fukuda Y; Nonen S; Hirobe S; Maeda S; Miwa Y; Yokoyama J; Nakayama H; Miyagawa S; Sawa Y; Fujio Y; Maeda M
Eur J Clin Pharmacol; 2019 Jul; 75(7):901-911. PubMed ID: 30852642
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of warfarin: development of a dosing algorithm for brazilian patients.
Perini JA; Struchiner CJ; Silva-Assunção E; Santana IS; Rangel F; Ojopi EB; Dias-Neto E; Suarez-Kurtz G
Clin Pharmacol Ther; 2008 Dec; 84(6):722-8. PubMed ID: 18754001
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Maintenance Dose Predictions by Warfarin Dosing Algorithms Based on Chinese and Western Patients.
Deng J; Wang Y; An X
J Clin Pharmacol; 2023 May; 63(5):569-582. PubMed ID: 36546564
[TBL] [Abstract][Full Text] [Related]
13. Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans.
Drozda K; Wong S; Patel SR; Bress AP; Nutescu EA; Kittles RA; Cavallari LH
Pharmacogenet Genomics; 2015 Feb; 25(2):73-81. PubMed ID: 25461246
[TBL] [Abstract][Full Text] [Related]
14. A pharmacogenetics-based warfarin maintenance dosing algorithm from Northern Chinese patients.
Chen J; Shao L; Gong L; Luo F; Wang J; Shi Y; Tan Y; Chen Q; Zhang Y; Hui R; Wang Y
PLoS One; 2014; 9(8):e105250. PubMed ID: 25126975
[TBL] [Abstract][Full Text] [Related]
15. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.
Johnson JA; Caudle KE; Gong L; Whirl-Carrillo M; Stein CM; Scott SA; Lee MT; Gage BF; Kimmel SE; Perera MA; Anderson JL; Pirmohamed M; Klein TE; Limdi NA; Cavallari LH; Wadelius M
Clin Pharmacol Ther; 2017 Sep; 102(3):397-404. PubMed ID: 28198005
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a Novel Warfarin Dosing Algorithm for Korean Patients With
Cho EH; Lee K; Yang M; Choi R; Baek SY; Sohn I; Kim JS; On YK; Bang OY; Cho HJ; Lee SY
Ann Lab Med; 2020 May; 40(3):216-223. PubMed ID: 31858761
[TBL] [Abstract][Full Text] [Related]
17. Ethnicity-specific pharmacogenetics: the case of warfarin in African Americans.
Hernandez W; Gamazon ER; Aquino-Michaels K; Patel S; O'Brien TJ; Harralson AF; Kittles RA; Barbour A; Tuck M; McIntosh SD; Douglas JN; Nicolae D; Cavallari LH; Perera MA
Pharmacogenomics J; 2014 Jun; 14(3):223-8. PubMed ID: 24018621
[TBL] [Abstract][Full Text] [Related]
18. Genotype-guided coumarin dosing: where are we now and where do we need to go next?
Baranova EV; Verhoef TI; Asselbergs FW; de Boer A; Maitland-van der Zee AH
Expert Opin Drug Metab Toxicol; 2015 Apr; 11(4):509-22. PubMed ID: 25595525
[TBL] [Abstract][Full Text] [Related]
19. Development and validation wise assessment of genotype guided warfarin dosing algorithm in Indian population.
Anand A; Kumar R; Sharma S; Gupta A; Vijayvergiya R; Mehrotra S; Kumar B; Lad D; Patil AN; Shafiq N; Malhotra S
Drug Metab Pers Ther; 2023 Sep; 38(3):273-279. PubMed ID: 37075481
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of genetic polymorphisms of CYP2C9 and VKORC1 - implications for warfarin management and outcome in Croatian patients with acute stroke.
Supe S; Božina N; Matijević V; Bazina A; Mišmaš A; Ljevak J; Alvir D; Habek M; Poljaković Z
J Neurol Sci; 2014 Aug; 343(1-2):30-5. PubMed ID: 24974237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
